Genome-wide Screen in S. Cerevisiae

Web supplement to
"Gene annotation and drug target discovery in C. albicans with a tagged transposon mutant collection "

Julia Oh, Eula Fung, Ulrich Schlecht, Ronald W. Davis, Guri Giaever, Robert P. St.Onge, Adam Deutschbauer, Corey Nislow

tbd

Figure S4: Confirmation of haploinsufficient phenotype with GRACE strains.

(A) The 17 “core” strains were monitored for growth over 20 population doublings in a microplate reader in triplicate, with representative curves shown. Every 5 generations, cells were robotically transferred to a well containing fresh media. Growth data from the 2nd (~10 generations), 3rd (~15 generations), or 4th (~20 generations) transfers was plotted against time (for some mutants, 15 or 20 generation growth data was not available). In all plots, black represents wild-type BWP17; each plot represents the mutants grown in a single plate with its own wild-type control. All curves were grown in selective SC media.

(B) The 12 GRACE strains [8] were grown in selective SC media over ~10-15 generations of growth. In (C), these mutants were grown in the presence of 100 mM doxycycline. In (D), the mean of triplicate AvgGs as percentage of wild-type growth were calculated for each curve. As growth curves in (A) were performed via robotic transfer, we were unable to calculate AvgGs for these curves. 

 

 

Inquiries can be addressed to guri.giaever@utoronto.ca OR corey.nislow@utoronto.ca